Study to Evaluate Broadlumab vs Placebo and Ustekinumab
Clinical trial NCT02786732 · TERMINATED
Trial details
- NCT number
- NCT02786732
- Sponsor
- MedDerm Associates
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2017-06-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.